Biocardia Stock Forward View - Price Action Indicator
| BCDA Stock | USD 1.26 0.04 3.08% |
Biocardia Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Biocardia stock prices and determine the direction of Biocardia's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Biocardia's historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the RSI of Biocardia's share price is approaching 44 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Biocardia, making its price go up or down. Momentum 44
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.29) | EPS Estimate Current Year (1.25) | EPS Estimate Next Year (0.69) | Wall Street Target Price 15.5 | EPS Estimate Current Quarter (0.25) |
Using Biocardia hype-based prediction, you can estimate the value of Biocardia from the perspective of Biocardia response to recently generated media hype and the effects of current headlines on its competitors.
Biocardia Relative Strength Index
Biocardia Hype to Price Pattern
Investor biases related to Biocardia's public news can be used to forecast risks associated with an investment in Biocardia. The trend in average sentiment can be used to explain how an investor holding Biocardia can time the market purely based on public headlines and social activities around Biocardia. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Biocardia's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Biocardia.
Biocardia after-hype prediction price | USD 1.26 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Biocardia | Build AI portfolio with Biocardia Stock |
Biocardia Additional Predictive Modules
Most predictive techniques to examine Biocardia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biocardia using various technical indicators. When you analyze Biocardia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.03) | (0.03) |
| Check Biocardia Volatility | Backtest Biocardia | Information Ratio |
Biocardia Trading Date Momentum
| On January 29 2026 Biocardia was traded for 1.26 at the closing time. The top price for the day was 1.30 and the lowest listed price was 1.23 . The trading volume for the day was 76.4 K. The trading history from January 29, 2026 did not affect price variability. The overall trading delta against the current closing price is 3.17% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Biocardia to competition |
Other Forecasting Options for Biocardia
For every potential investor in Biocardia, whether a beginner or expert, Biocardia's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Biocardia Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Biocardia. Basic forecasting techniques help filter out the noise by identifying Biocardia's price trends.Biocardia Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biocardia stock to make a market-neutral strategy. Peer analysis of Biocardia could also be used in its relative valuation, which is a method of valuing Biocardia by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Biocardia Market Strength Events
Market strength indicators help investors to evaluate how Biocardia stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biocardia shares will generate the highest return on investment. By undertsting and applying Biocardia stock market strength indicators, traders can identify Biocardia entry and exit signals to maximize returns.
Biocardia Risk Indicators
The analysis of Biocardia's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Biocardia's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biocardia stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.65 | |||
| Standard Deviation | 3.58 | |||
| Variance | 12.8 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Biocardia
The number of cover stories for Biocardia depends on current market conditions and Biocardia's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biocardia is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biocardia's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Biocardia Short Properties
Biocardia's future price predictability will typically decrease when Biocardia's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biocardia often depends not only on the future outlook of the potential Biocardia's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biocardia's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.7 M | |
| Cash And Short Term Investments | 2.4 M |
Check out Historical Fundamental Analysis of Biocardia to cross-verify your projections. For information on how to trade Biocardia Stock refer to our How to Trade Biocardia Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biocardia. Projected growth potential of Biocardia fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Biocardia assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Biocardia requires distinguishing between market price and book value, where the latter reflects Biocardia's accounting equity. The concept of intrinsic value—what Biocardia's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Biocardia's price substantially above or below its fundamental value.
It's important to distinguish between Biocardia's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biocardia should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biocardia's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.